Results 251 to 260 of about 76,552 (356)
ABSTRACT Cannabinoids, such as tetrahydrocannabinolic acid (THCA), cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA), are bioactive and medicinally relevant compounds found in the cannabis plant (Cannabis sativa L.). These three compounds are synthesised from a single precursor, cannabigerolic acid (CBGA), through regioselective reactions ...
Cloé Villard +5 more
wiley +1 more source
Lenalidomide-Associated Liver Injury With Features of Vanishing Bile Duct Syndrome in Multiple Myeloma. [PDF]
Alajpur S, Farooq A.
europepmc +1 more source
METABOLISM OF HUMAN GAMMA GLOBULIN ( SS-globulin) [PDF]
openaire +1 more source
ABSTRACT Enhancing both starch and protein accumulation is a key strategy for improving maize yield and quality. Achieving this goal requires an in‐depth understanding of the regulatory mechanisms that integrate these pathways. Here, we demonstrate that functionally redundant subclass III SNF1‐related protein kinase 2s (SnRK2s) act as central ...
Yayun Wang +16 more
wiley +1 more source
On the stability of acid-soluble pea protein-stabilized beverage emulsions against salt addition and heat treatment. [PDF]
Nasrabadi MN +3 more
europepmc +1 more source
The role of acquired host immunity in periodontal diseases
Abstract The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease.
Denis F. Kinane +2 more
wiley +1 more source
Percent Pulmonary Damage on Hospital Admission is Predictive of COVID-19 Aggravation, but Serum Protein Electrophoresis is Not. [PDF]
Mascio SD +4 more
europepmc +1 more source
A sudden increase in EBV DNAemia appears to be a better predictor of PTLD and EBV end‐organ disease than persistent and stable levels of EBV DNAemia. Most HCT recipients with EBV DNAemia did not require rituximab, and immunosuppression reduction was sufficient to control most episodes of EBV reactivation.
Anna Beatriz Coelho de Souza +12 more
wiley +1 more source

